Literature DB >> 32634485

Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.

Mira Reichman1, Eric Riklin2, Eric Macklin3, Ana-Maria Vranceanu4.   

Abstract

BACKGROUND: Neurofibromatoses (NF) are a group of genetically distinct disorders of the nervous system unified by the predisposition to nerve sheath tumors. Although adolescents with NF types 1 and 2 (NF1 and NF2) report poor quality of life and high psychosocial burden, there are no evidence-based interventions to address these needs. This paper presents the study design and protocol for the first randomized controlled trial (RCT) of a mind-body intervention for adolescents with NF, Resilient Youth with NF (RY-NF), versus an educational control group, Health Education for NF (HE-NF), both delivered in groups via secure live video.
METHODS: This is an ongoing, single-blind efficacy RCT. Recruitment began in November 2019 and will continue until March 2022. We will enroll 200 English-speaking, geographically diverse adolescents (ages 12-17) with NF1 and NF2 who report significant distress or difficulty coping with their NF symptoms. We will use a shared-baseline, linear mixed model to compare the effect of RY-NF versus HE-NF on changes in quality of life (QoL) and psychosocial outcomes from baseline to post-intervention, and 6- and 12-month follow-ups. We will also develop NF-specific minimal clinically important difference (MCID) for QoL variables, and conduct mediation and moderation analyses to understand mechanisms of improvement. DISCUSSION: This study has important clinical and public health implications for the psychosocial functioning of adolescents with NF. It provides a model for efficient delivery of virtual psychosocial care for adolescents with rare diseases. Plans for dissemination and implementation of the RY-NF should efficacy be ascertained are also discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; Mind-body program; Neurofibromatoses; Quality of life; Resiliency

Year:  2020        PMID: 32634485     DOI: 10.1016/j.cct.2020.106078

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  3 in total

1.  Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.

Authors:  Nathan S Fishbein; Ana-Maria Vranceanu; Ryan A Mace
Journal:  J Neurooncol       Date:  2022-08-04       Impact factor: 4.506

2.  The Strategies for Quantitative and Qualitative Remote Data Collection: Lessons From the COVID-19 Pandemic.

Authors:  Keenae Tiersma; Mira Reichman; Paula J Popok; Zoe Nelson; Maura Barry; A Rani Elwy; Efrén J Flores; Kelly E Irwin; Ana-Maria Vranceanu
Journal:  JMIR Form Res       Date:  2022-04-08

3.  A Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed Methods Study.

Authors:  Jonathan Greenberg; Tanya Singh; Grant L Iverson; Noah D Silverberg; Eric A Macklin; Robert A Parker; Joseph T Giacino; Gloria Y Yeh; Ana-Maria Vranceanu
Journal:  JMIR Res Protoc       Date:  2021-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.